Back
Nektar Therapeutics Stock Price Chart
Sponsored
NKTR
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
41
NKTR
Nektar Therapeutics
Last Price:
1.30
Seasonality Move:
4.53%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.
Nektar Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.28 | Buy |
20-day SMA: | 1.26 | Buy |
50-day SMA: | 1.28 | Buy |
200-day SMA: | 1.07 | Buy |
8-day EMA: | 1.27 | Buy |
20-day EMA: | 1.26 | Buy |
50-day EMA: | 1.26 | Buy |
200-day EMA: | 1.19 | Buy |
Nektar Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 53.51 | Buy |
Chaikin Money Flow: | 664758 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.2 - 1.32) | Buy |
Bollinger Bands (100): | (1.16 - 1.54) | Sell |
Nektar Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
- Nektar Therapeutics share price is 1.29 while NKTR 8-day simple moving average is 1.28, which is a Buy signal.
- The stock price of NKTR is 1.29 while Nektar Therapeutics 20-day SMA is 1.26, which makes it a Buy.
- Nektar Therapeutics 50-day simple moving average is 1.28 while NKTR share price is 1.29, making it a Buy technically.
- NKTR stock price is 1.29 and Nektar Therapeutics 200-day simple moving average is 1.07, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
41
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a Sell
The current Nektar Therapeutics [NKTR] share price is $1.29. The Score for NKTR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
237.46M
Price in USD:
1.29
Share Volume:
1.61M
Nektar Therapeutics 52-Week Range
52-Week High:
1.93
52-Week Low:
0.41
Sell
41
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?
The Nektar Therapeutics stock price is 1.29 USD today. -
Will NKTR stock go up or go down?
Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Nektar Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
- Nektar Therapeutics share price is 1.29 while NKTR 8-day exponential moving average is 1.27, which is a Buy signal.
- The stock price of NKTR is 1.29 while Nektar Therapeutics 20-day EMA is 1.26, which makes it a Buy.
- Nektar Therapeutics 50-day exponential moving average is 1.26 while NKTR share price is 1.29, making it a Buy technically.
- NKTR stock price is 1.29 and Nektar Therapeutics 200-day simple moving average is 1.19, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and a decrease next year of $0.06 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
- NKTR Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Nektar Therapeutics is a Buy
- Nektar Therapeutics Relative Strength Index (RSI) is 53.51, which suggest Nektar Therapeutics is overbought
- The Bollinger Bands (25) for Nektar Therapeutics is (1.2 - 1.32), which suggest Nektar Therapeutics is a Sell
- The Bollinger Bands (100) for Nektar Therapeutics is (1.16 - 1.54), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.